Agarose-based biomaterials for advanced drug delivery

  • Mohsen Khodadadi Yazdi
  • , Ali Taghizadeh
  • , Mohsen Taghizadeh
  • , Florian J. Stadler
  • , Mehdi Farokhi
  • , Fatemeh Mottaghitalab
  • , Payam Zarrintaj*
  • , Joshua D. Ramsey
  • , Farzad Seidi
  • , Mohammad Reza Saeb
  • , Masoud Mozafari
  • *Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

244 Scopus citations

Abstract

Agarose is a prominent marine polysaccharide representing reversible thermogelling behavior, outstanding mechanical properties, high bioactivity, and switchable chemical reactivity for functionalization. As a result, agarose has received particular attention in the fabrication of advanced delivery systems as sophisticated carriers for therapeutic agents. The ever-growing use of agarose-based biomaterials for drug delivery systems resulted in rapid growth in the number of related publications, however still, a long way should be paved to achieve FDA approval for most of the proposed products. This review aims at a classification of agarose-based biomaterials and their derivatives applicable for controlled/targeted drug delivery purposes. Moreover, it attempts to deal with opportunities and challenges associated with the future developments ahead of agarose-based biomaterials in the realm of advanced drug delivery. Undoubtedly, this class of biomaterials needs further advancement, and a lot of critical questions have yet to be answered.

Original languageEnglish
Pages (from-to)523-543
Number of pages21
JournalJournal of Controlled Release
Volume326
DOIs
StatePublished - 10 Oct 2020
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2020

Keywords

  • Agarose
  • Biomaterials
  • Controlled release
  • Drug delivery
  • Natural polymers

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'Agarose-based biomaterials for advanced drug delivery'. Together they form a unique fingerprint.

Cite this